Japanese medical-device maker OMRON Healthcare has begun full-scale production of blood pressure monitors at its first manufacturing plant in India, located near Chennai, Tamil Nadu. The facility marks a major expansion of the company’s local manufacturing operations and is intended to strengthen supplies for India’s growing home-healthcare market.
The 24,000-square-metre factory, operated by OMRON Healthcare Manufacturing India Pvt. Ltd., has five production lines. OMRON plans to increase its production capacity tenfold by 2028, targeting around three million blood pressure monitors annually. The company also wants to develop Chennai into a manufacturing and export base for international markets.
Key Takeaways
- OMRON Healthcare began full-scale production at its first Indian factory near Chennai on October 30, 2026.
- The facility is located at ORIGINS by Mahindra in Tamil Nadu and covers approximately 24,000 square metres.
- It currently operates five production lines.
- The factory manufactures three blood pressure monitor series: HEM-7090, HEM-7181 and HEM-7183T.
- OMRON aims to increase annual production capacity tenfold by 2028, targeting approximately three million units.
- The company is exploring Chennai as a supply base for international markets, including Europe.
- OMRON wants to introduce nebulizer manufacturing at the facility in the future.
- The investment supports India’s Make in India initiative and the expansion of domestic medical-device manufacturing.
OMRON Begins Full-Scale Production at Its First Indian Factory
OMRON Healthcare, the medical-device division of Japan’s OMRON Corporation, has started full-scale production at its first manufacturing facility in India.
The factory is located at ORIGINS by Mahindra near Chennai, Tamil Nadu. It is operated by OMRON Healthcare Manufacturing India Pvt. Ltd., a company established in July 2022.
The facility covers approximately 24,000 square metres and currently has five production lines dedicated to blood pressure monitors.
OMRON said the factory uses manufacturing technologies and quality-control practices developed at its facilities in Matsusaka, Japan, and Vietnam.
The company intends to manufacture devices for Indian consumers while gradually expanding the facility’s role in its international manufacturing network.
OMRON Chennai factory: Key details
| Particulars | Details |
|---|---|
| Company | OMRON Healthcare |
| Manufacturing subsidiary | OMRON Healthcare Manufacturing India Pvt. Ltd. |
| Location | ORIGINS by Mahindra, Chennai region, Tamil Nadu |
| Factory area | Approximately 24,000 sq. metres |
| Production lines | 5 |
| Full-scale production | October 2026 |
| Managing director | Takuto Iwanaka |
| Capitalisation | ₹191 crore |
| Current workforce | Approximately 120 employees |
| Expansion target | 10x production capacity by 2028 |
The factory represents OMRON’s move towards building a stronger manufacturing presence in India rather than depending primarily on production facilities in other countries.
Which Blood Pressure Monitors Will OMRON Manufacture in India?
The Chennai factory has started manufacturing three blood pressure monitor series designed for different consumer requirements.
The products range from basic home-monitoring devices to more advanced models with digital connectivity.
1. HEM-7090 Series
The HEM-7090 is a standard upper-arm blood pressure monitor designed for straightforward home measurement.
It is intended to make blood pressure monitoring accessible to first-time users and households looking for a simple device.
2. HEM-7181 Series
The HEM-7181 includes additional features compared with the basic model.
Its features include:
- Trend Indicator to help users identify increases in blood pressure readings.
- Memory functionality to record previous measurements.
- Upper-arm measurement design.
3. HEM-7183T Series
The HEM-7183T is the more connected model among the three products.
Its features include:
- Bluetooth connectivity.
- Compatibility with the OMRON Connect health-management application.
- Trend Indicator.
- Fit Cuff designed for easier wrapping.
The connected application allows users to manage and review their blood pressure measurements digitally.
These products are being manufactured using production and quality-control methods transferred from OMRON’s established factories in Japan and Vietnam.
OMRON Targets Three Million Blood Pressure Monitors Annually by 2028
One of the most important parts of OMRON’s India strategy is its planned manufacturing expansion.
The company aims to increase the Chennai factory’s production capacity tenfold by 2028.
According to Reuters, the target is approximately three million blood pressure monitors annually. The plant could potentially reach around 3.5 million units if it operates in three shifts.
| Production metric | Target |
|---|---|
| Planned capacity expansion | 10 times |
| Target year | 2028 |
| Annual production target | Approximately 3 million units |
| Potential capacity with three shifts | Approximately 3.5 million units |
The expansion is expected to strengthen India’s domestic supply of blood pressure monitors while creating opportunities for exports.
OMRON has also indicated that Chennai could become an important manufacturing base within its global production network.
Why Is OMRON Expanding Manufacturing in India?
OMRON’s decision reflects two major business opportunities: India’s growing demand for home-healthcare devices and the need to diversify its manufacturing operations.
India’s hypertension market offers significant potential
India has a large population of people living with high blood pressure.
OMRON estimates that approximately 300 million people in the country have hypertension. However, fewer than 5% of Indian households regularly use a home blood pressure monitor, according to the company.
This creates an opportunity for manufacturers of home-healthcare equipment.
Blood pressure monitors allow people to track readings outside hospitals and clinics, helping patients and healthcare professionals monitor changes over time.
OMRON wants to encourage wider adoption of home monitoring through locally manufactured devices, awareness campaigns and cooperation with healthcare professionals.
The company has also worked with the Indian Society of Hypertension on the development of India’s first home blood pressure monitoring guidelines.
Reducing dependence on Vietnam
Another important reason behind the factory is supply-chain diversification.
OMRON has relied heavily on its manufacturing operations in Vietnam for blood pressure monitors.
Company leadership has indicated that depending too heavily on a single manufacturing location creates risks in the event of disruptions, natural disasters or other unexpected events.
The Chennai factory gives OMRON another production base and provides greater flexibility in serving different markets.
Reuters reported that OMRON wants to reduce its dependence on Vietnam while making India one of its important manufacturing locations.
Chennai Could Become an Export Hub for OMRON
Initially, the factory will manufacture blood pressure monitors primarily for the Indian market.
However, OMRON has broader plans for the facility.
The company wants to use Chennai as a supply base for international markets, including Europe. This would allow it to diversify exports currently supplied from Vietnam.
India’s manufacturing ecosystem, industrial infrastructure and access to international shipping routes could support this expansion.
The company’s longer-term plans also include introducing nebulizer production at the Chennai facility.
Nebulizers are medical devices used to deliver medication in mist form for inhalation, including in the treatment of respiratory conditions such as asthma.
If this plan progresses, the factory could eventually manufacture a wider range of home-healthcare products rather than focusing exclusively on blood pressure monitors.
OMRON’s India Business and Market Position
OMRON Healthcare has operated in India since 2010 and has established a presence in the country’s home blood pressure monitoring market.
The company reported revenue of ₹246 crore in FY25, according to the PTI report carried by Moneycontrol.
Reuters reported that OMRON held approximately 40% of India’s blood pressure monitor market in 2025, based on company data.
The company has also expanded its sales through e-commerce and quick-commerce platforms.
Globally, OMRON Healthcare has sold more than 400 million home-use digital blood pressure monitors and supplies products in over 130 countries.
The Indian factory gives the company an opportunity to combine its international manufacturing experience with local production and distribution.
How the Factory Supports India’s Make in India Initiative
The Chennai plant is also aligned with India’s effort to expand domestic manufacturing of medical devices.
India has historically depended on imports for several categories of medical equipment and healthcare technology.
Local manufacturing can help strengthen supply chains, develop technical skills and create employment opportunities.
OMRON says the facility will support:
- Local component sourcing.
- Workforce development.
- Manufacturing employment.
- Domestic availability of medical-grade devices.
- Future exports to international markets.
The company currently employs approximately 120 people at the factory, with additional opportunities expected as production capacity expands.
However, the extent of local sourcing will be important in determining how much value the facility adds to India’s domestic medical-device manufacturing ecosystem.
The Bigger Picture
OMRON’s Chennai factory reflects the growing importance of India as a manufacturing destination for global healthcare companies. The combination of a large domestic market, rising demand for preventive healthcare and opportunities to diversify international supply chains is attracting investment in medical devices. For OMRON, local production can strengthen domestic distribution while reducing its reliance on a single overseas manufacturing base.
The next challenge will be expanding production while developing a stronger local supplier network and maintaining international quality standards. If the company reaches its three-million-unit annual production target by 2028, Chennai could become an important part of its global manufacturing operations. The planned addition of nebulizers would also broaden the facility’s role in India’s home-healthcare industry.
Looking Ahead
OMRON’s immediate priority is to expand production at the Chennai facility and strengthen the supply of blood pressure monitors for Indian consumers. Its tenfold capacity expansion target by 2028 will be an important milestone, alongside efforts to increase local component sourcing and develop Chennai as an export base.
For India’s medical-device industry, the investment represents another step towards building domestic manufacturing capabilities. The longer-term impact will depend on how quickly the facility scales, whether it begins exporting at meaningful volumes and whether OMRON introduces additional healthcare products at the site.
Frequently Asked Questions
1. Has OMRON started manufacturing blood pressure monitors in India?
Yes. OMRON Healthcare began full-scale production at its first Indian factory near Chennai, Tamil Nadu, on October 30, 2026.
2. Where is OMRON’s first Indian manufacturing plant located?
The factory is located at ORIGINS by Mahindra near Chennai in Tamil Nadu. It covers approximately 24,000 square metres.
3. Which OMRON products are manufactured at the Chennai factory?
The facility currently manufactures three blood pressure monitor series: HEM-7090, HEM-7181 and HEM-7183T.
4. What is OMRON’s production target for 2028?
OMRON aims to increase the factory’s production capacity tenfold by 2028, targeting approximately three million blood pressure monitors annually.
5. How much has OMRON invested in its Indian manufacturing subsidiary?
OMRON Healthcare Manufacturing India Pvt. Ltd. has a reported capitalisation of ₹191 crore.
6. Why is OMRON manufacturing blood pressure monitors in India?
The company wants to strengthen domestic supply, serve India’s growing home-healthcare market, diversify production beyond Vietnam and develop Chennai as a potential export base.
7. Will OMRON manufacture products other than blood pressure monitors in India?
The company plans to introduce nebulizer production at the Chennai facility in the future, although a specific manufacturing start date has not been announced.
8. How many people does OMRON employ in India?
The Chennai factory has approximately 120 employees. OMRON’s wider India operations employ around 210 people, according to the company’s reported figures.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
